Stage FocusSeed, Series A
GeographyUS
TypeLongevity-Focused Biotech VC
Last Activity-
Industry Focus
Industries
BiotechSynthetic Biology
Technical BenchLimited
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Longevity Fund, founded in 2014 by Laura Deming — who joined MIT's aging biology lab at age 14 — is a San Francisco-based pioneer that helped establish longevity therapeutics as a venture category. With $37M across three funds, the firm invests at seed and Series A in senolytics, aging biology, and healthspan-extending therapeutics. Portfolio companies including Unity Biotechnology, Precision Bios...
Similar Funds
Ahren Innovation Capital
London, United Kingdom
DeepTech NativeBiotechRoboticsClimate TechSeedSeries A
CC
Casdin Capital
New York, United States
DeepTech NativeBiotechMedtechSynthetic BiologySeedSeries A
Civilization Ventures
San Francisco, United States
DeepTech NativeBiotechSynthetic BiologyAISeedSeries A
EV
Excel Venture Management
United States
DeepTech NativeBiotechMedtechSynthetic BiologySeedSeries A
Genoa Ventures
San Francisco, United States
DeepTech NativeBiotechSynthetic BiologyMedtechSeedSeries A
KV
Kicker Ventures
Menlo Park, United States
DeepTech NativeBiotechNeurotechSynthetic BiologyPre-SeedSeed